{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:19:14Z","timestamp":1783556354306,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Suzhou Youth Science and Technology Project","award":["QNXM2024068"],"award-info":[{"award-number":["QNXM2024068"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272687"],"award-info":[{"award-number":["82272687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02509-3","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:25:12Z","timestamp":1778891112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP43 Inhibits Intestinal Inflammation via TRAF4-mediated NF-\u03baB Signaling"],"prefix":"10.1007","volume":"49","author":[{"given":"Li","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhencheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"1","key":"2509_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T., B. Siegmund, C. Le Berre, et al. 2020. Ulcerative colitis. Nature Reviews Disease Primers 6 (1): 74.","journal-title":"Nature Reviews Disease Primers"},{"issue":"10401","key":"2509_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre, C., S. Honap, and L. Peyrin-Biroulet. 2023. Ulcerative colitis. Lancet 402 (10401): 571\u2013584.","journal-title":"Lancet"},{"issue":"2","key":"2509_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41435-023-00199-7","volume":"24","author":"STQ de Andrade","year":"2023","unstructured":"de Andrade, S. T. Q., T. I. Guidugli, A. Borrego, et al. 2023. Slc11a1 gene polymorphism influences dextran sulfate sodium (DSS)-induced colitis in a murine model of acute inflammation. Genes and Immunity 24 (2): 71\u201380.","journal-title":"Genes and Immunity"},{"issue":"1","key":"2509_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jgh.16804","volume":"40","author":"Y Ji","year":"2025","unstructured":"Ji, Y., P. Li, T. Ning, et al. 2025. PANoptosis-related genes: Molecular insights into immune dysregulation in ulcerative colitis. Journal of Gastroenterology and Hepatology 40 (1): 177\u2013191.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"2509_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128191","volume":"297","author":"Z Liu","year":"2025","unstructured":"Liu, Z., H. Zhang, J. Wang, et al. 2025. Clca1 deficiency exacerbates colitis susceptibility via impairment of mucus barrier integrity and gut microbiota homeostasis. Microbiological Research 297 : 128191.","journal-title":"Microbiological Research"},{"issue":"8","key":"2509_CR6","doi-asserted-by":"publisher","first-page":"110016","DOI":"10.1016\/j.celrep.2021.110016","volume":"37","author":"CS Chang","year":"2021","unstructured":"Chang, C. S., Y. C. Liao, C. T. Huang, et al. 2021. Identification of a gut microbiota member that ameliorates DSS-induced colitis in intestinal barrier enhanced Dusp6-deficient mice. Cell Reports 37 (8): 110016.","journal-title":"Cell Reports"},{"issue":"7","key":"2509_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.chembiol.2023.05.009","volume":"30","author":"YX Liu","year":"2023","unstructured":"Liu, Y. X., S. Wan, X. Q. Yang, et al. 2023. TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2. Cell Chemical Biology 30 (7): 709-725 e6.","journal-title":"Cell Chemical Biology"},{"issue":"42","key":"2509_CR8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406936121","volume":"121","author":"WL Ye","year":"2024","unstructured":"Ye, W.L., L. Huang, X.Q. Yang, et al. 2024. TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 121 (42): e2406936121.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"2509_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.molmed.2022.01.006","volume":"28","author":"J Ruan","year":"2022","unstructured":"Ruan, J., D. Schluter, M. Naumann, et al. 2022. Ubiquitin-modifying enzymes as regulators of colitis. Trends in Molecular Medicine 28 (4): 304\u2013318.","journal-title":"Trends in Molecular Medicine"},{"issue":"6","key":"2509_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.152026","volume":"225","author":"Y Xiao","year":"2020","unstructured":"Xiao, Y., Q. Huang, Z. Wu, et al. 2020. Roles of protein ubiquitination in inflammatory bowel disease. Immunobiology 225 (6): 152026.","journal-title":"Immunobiology"},{"issue":"2","key":"2509_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41423-021-00810-9","volume":"19","author":"B Wu","year":"2022","unstructured":"Wu, B., L. Qiang, Y. Zhang, et al. 2022. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-kappaB signaling. Cellular & Molecular Immunology 19 (2): 276\u2013289.","journal-title":"Cellular & Molecular Immunology"},{"issue":"2","key":"2509_CR12","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.apsb.2024.12.012","volume":"15","author":"X Liu","year":"2025","unstructured":"Liu, X., Y. Fang, M. Huang, et al. 2025. Deubiquitinase JOSD2 alleviates colitis by inhibiting inflammation via deubiquitination of IMPDH2 in macrophages. Acta Pharmaceutica Sinica B 15 (2): 1039\u20131055.","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"9","key":"2509_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41422-018-0079-6","volume":"28","author":"L He","year":"2018","unstructured":"He, L., X. Liu, J. Yang, et al. 2018. Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR\/PI3K\/AKT drives breast carcinogenesis. Cell Research 28 (9): 934\u2013951.","journal-title":"Cell Research"},{"issue":"1","key":"2509_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","volume":"15","author":"M Li","year":"2024","unstructured":"Li, M., J. Yu, L. Ju, et al. 2024. USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer. Cell Death & Disease 15 (1): 44.","journal-title":"Cell Death & Disease"},{"key":"2509_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114217","volume":"149","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Y. Liu, Q. Deng, et al. 2025. USP43 drives cervical carcinoma progression through regulation of the Hippo\/TAZ pathway. International Immunopharmacology 149 : 114217.","journal-title":"International Immunopharmacology"},{"key":"2509_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01491-x","author":"X Zhao","year":"2025","unstructured":"Zhao, X., Q. Di, J. Chen, et al. 2025. The USP43\/RNF2 axis negatively regulates antiviral innate immunity by promoting TBK1 ubiquitination and degradation. Cell Death and Differentiation. https:\/\/doi.org\/10.1038\/s41418-025-01491-x.","journal-title":"Cell Death and Differentiation"},{"issue":"2","key":"2509_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.7150\/jca.48056","volume":"12","author":"DX Ye","year":"2021","unstructured":"Ye, D. X., S. S. Wang, Y. Huang, et al. 2021. USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer. Journal of Cancer 12 (2): 404\u2013416.","journal-title":"Journal of Cancer"},{"issue":"12","key":"2509_CR18","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1007\/s10620-022-07453-4","volume":"67","author":"S Wang","year":"2022","unstructured":"Wang, S., J. Pu, X. Li, et al. 2022. UBE2W improves the experimental colitis by inhibiting the NF-kappaB signaling pathway. Digestive Diseases and Sciences 67 (12): 5529\u20135539.","journal-title":"Digestive Diseases and Sciences"},{"issue":"11","key":"2509_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by toll-like receptors. Trends in Molecular Medicine 13 (11): 460\u2013469.","journal-title":"Trends in Molecular Medicine"},{"issue":"12","key":"2509_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2157-1","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen, X., G. Liu, and Y. Yuan. 2019. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-kappaB signaling. Cell Death & Disease 10 (12): 906.","journal-title":"Cell Death & Disease"},{"key":"2509_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01849","volume":"9","author":"JH Shi","year":"2018","unstructured":"Shi, J.H., and S.C. Sun. 2018. Tumor necrosis factor receptor-associated factor regulation of nuclear factor kappaB and mitogen-activated protein kinase pathways. Frontiers in Immunology 9: 1849.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"2509_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/path.4670","volume":"238","author":"H Wu","year":"2016","unstructured":"Wu, H., X.M. Li, J.R. Wang, et al. 2016. NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6\/TLR-IL-1R signalling axis. The Journal of Pathology 238 (3): 457\u2013469.","journal-title":"The Journal of Pathology"},{"issue":"8","key":"2509_CR23","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s11427-021-2040-8","volume":"65","author":"H Lei","year":"2022","unstructured":"Lei, H., L. Yang, H. Xu, et al. 2022. Ubiquitin-specific protease 47 regulates intestinal inflammation through deubiquitination of TRAF6 in epithelial cells. Science China. Life Sciences 65 (8): 1624\u20131635.","journal-title":"Science China. Life Sciences"},{"key":"2509_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169736","author":"J Xiao","year":"2023","unstructured":"Xiao, J., X. Chen, W. Liu, et al. 2023. TRAF4 is crucial for ST2+ memory Th2 cell expansion in IL-33-driven airway inflammation. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.169736.","journal-title":"JCI Insight"},{"issue":"12","key":"2509_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301164","volume":"11","author":"L Zhao","year":"2024","unstructured":"Zhao, L., N. Gao, X. Peng, et al. 2024. TRAF4-mediated LAMTOR1 ubiquitination promotes mTORC1 activation and inhibits the inflammation-induced colorectal cancer progression. Advanced Science 11 (12): e2301164.","journal-title":"Advanced Science"},{"issue":"1","key":"2509_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12950-024-00393-y","volume":"21","author":"L Zhou","year":"2024","unstructured":"Zhou, L., L. Zhang, Y. Lv, et al. 2024. YTHDC1 inhibits autophagy-dependent NF-kappaB signaling by stabilizing Beclin1 mRNA in macrophages. Journal of Inflammation 21 (1): 22.","journal-title":"Journal of Inflammation"},{"issue":"6","key":"2509_CR27","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-023-01148-7","volume":"30","author":"X Liu","year":"2023","unstructured":"Liu, X., Y. Fang, X. Lv, et al. 2023. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3. Cell Death and Differentiation 30 (6): 1457\u20131471.","journal-title":"Cell Death and Differentiation"},{"issue":"7","key":"2509_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nri2337","volume":"8","author":"SC Sun","year":"2008","unstructured":"Sun, S.C. 2008. Deubiquitylation and regulation of the immune response. Nature Reviews. Immunology 8 (7): 501\u2013511.","journal-title":"Nature Reviews. Immunology"},{"issue":"36","key":"2509_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303807","volume":"10","author":"J Ren","year":"2023","unstructured":"Ren, J., P. Yu, S. Liu, et al. 2023. Deubiquitylating enzymes in cancer and immunity. Advanced Science 10 (36) : e2303807.","journal-title":"Advanced Science"},{"issue":"1","key":"2509_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12964-024-01633-7","volume":"22","author":"SK Hsu","year":"2024","unstructured":"Hsu, S. K., C. K. Chou, I. L. Lin, et al. 2024. Deubiquitinating enzymes: Potential regulators of the tumor microenvironment and implications for immune evasion. Cell Communication and Signaling 22 (1): 259.","journal-title":"Cell Communication and Signaling"},{"issue":"5\u20136","key":"2509_CR31","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s10495-025-02095-z","volume":"30","author":"C Liu","year":"2025","unstructured":"Liu, C., Y. Yuan, Y. Zhan, et al. 2025. Role of the USP family in autophagy regulation and cancer progression. Apoptosis 30 (5\u20136): 1133\u20131151.","journal-title":"Apoptosis"},{"issue":"10","key":"2509_CR32","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ibd\/izz149","volume":"25","author":"D Yao","year":"2019","unstructured":"Yao, D., M. Dong, C. Dai, et al. 2019. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflammatory Bowel Diseases 25 (10): 1595\u20131602.","journal-title":"Inflammatory Bowel Diseases"},{"issue":"818","key":"2509_CR33","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1126\/scisignal.adh1641","volume":"17","author":"T Mukherjee","year":"2024","unstructured":"Mukherjee, T., N. Kumar, M. Chawla, et al. 2024. The NF-kappaB signaling system in the immunopathogenesis of inflammatory bowel disease. Science Signaling 17 (818): 1641.","journal-title":"Science Signaling"},{"issue":"2","key":"2509_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113688","volume":"43","author":"XM Li","year":"2024","unstructured":"Li, X. M., Y. Yang, F. Q. Jiang, et al. 2024. Histone lactylation inhibits RARgamma expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling. Cell Reports 43 (2) : 113688.","journal-title":"Cell Reports"},{"issue":"1\u20132","key":"2509_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s10495-023-01873-x","volume":"29","author":"L Pei","year":"2024","unstructured":"Pei, L., F. Zhao, and Y. Zhang. 2024. USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt\/beta-catenin signaling pathway. Apoptosis\u202f: An International Journal on Programmed Cell Death 29 (1\u20132): 210\u2013228.","journal-title":"Apoptosis : An International Journal on Programmed Cell Death"},{"key":"2509_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500741","author":"C Qian","year":"2025","unstructured":"Qian, C., C. Hu, Y. Xu, et al. 2025. Intestinal epithelial-derived USP13 alleviates colonic inflammation by suppressing GRP78-mediated endoplasmic reticulum stress. Advanced Science. https:\/\/doi.org\/10.1002\/advs.202500741.","journal-title":"Advanced Science"},{"issue":"3","key":"2509_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.103017","volume":"21","author":"H Nakase","year":"2022","unstructured":"Nakase, H., N. Sato, N. Mizuno, et al. 2022. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmunity Reviews 21 (3): 103017.","journal-title":"Autoimmunity Reviews"},{"issue":"9","key":"2509_CR38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece, D., D. Verzella, I. Flati, et al. 2022. NF-kappaB: Blending metabolism, immunity, and inflammation. Trends in Immunology 43 (9): 757\u2013775.","journal-title":"Trends in Immunology"},{"issue":"1","key":"2509_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05098-8","volume":"81","author":"N Ebrahimi","year":"2024","unstructured":"Ebrahimi, N., A.R.R. Abdulwahid, and A. Mansouri. 2024. Targeting the NF-kappaB pathway as a potential regulator of immune checkpoints in cancer immunotherapy. Cellular and Molecular Life Sciences 81 (1): 106.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"11","key":"2509_CR40","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","volume":"31","author":"A Khan","year":"2024","unstructured":"Khan, A., Y. Zhang, N. Ma, et al. 2024. NF-kappaB role on tumor proliferation, migration, invasion and immune escape. Cancer Gene Therapy 31 (11): 1599\u20131610.","journal-title":"Cancer Gene Therapy"},{"issue":"6","key":"2509_CR41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","volume":"263","author":"I Atreya","year":"2008","unstructured":"Atreya, I., R. Atreya, and M.F. Neurath. 2008. NF-kappaB in inflammatory bowel disease. Journal of Internal Medicine 263 (6): 591\u2013596.","journal-title":"Journal of Internal Medicine"},{"key":"2509_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.944528","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Y. Li, P.T. Li, et al. 2022. Novel findings in teleost TRAF4, a protein acts as an enhancer in TRIF and TRAF6 mediated antiviral and inflammatory signaling. Frontiers in Immunology 13: 944528.","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"2509_CR43","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1002\/eji.200526151","volume":"35","author":"F Takeshita","year":"2005","unstructured":"Takeshita, F., K.J. Ishii, K. Kobiyama, et al. 2005. TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. European Journal of Immunology 35 (8): 2477\u20132485.","journal-title":"European Journal of Immunology"},{"issue":"3","key":"2509_CR44","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1074\/jbc.M110.189308","volume":"286","author":"JM Marinis","year":"2011","unstructured":"Marinis, J.M., C.R. Homer, C. McDonald, et al. 2011. A novel motif in the Crohn\u2019s disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses. Journal of Biological Chemistry 286 (3): 1938\u20131950.","journal-title":"Journal of Biological Chemistry"},{"key":"2509_CR45","doi-asserted-by":"publisher","first-page":"111704","DOI":"10.1016\/j.cellsig.2025.111704","volume":"131","author":"H Liu","year":"2025","unstructured":"Liu, H., S. Tan, Z. Li, et al. 2025. OTUB1 promotes glioma progression by stabilizing TRAF4. Cellular Signalling 131:111704.","journal-title":"Cellular Signalling"},{"issue":"1","key":"2509_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03123-22","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang, Y., M. Chang, M. Wang, et al. 2023. OTU7B modulates the mosquito immune response to Beauveria bassiana infection via deubiquitination of the Toll adaptor TRAF4. Microbiology Spectrum 11 (1): e0312322.","journal-title":"Microbiology Spectrum"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02509-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02509-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02509-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:03:53Z","timestamp":1783555433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02509-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2509"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02509-3","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}